Alcon appointed Timothy C. Stonesifer as its new senior vice president and chief financial officer, effective on April 9. Stonesifer succeeds David Murray, who decided to remain with Novartis and return to Europe. At their annual general meeting, the shareholders of Novartis approved the separation of the Alcon eye care ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.